Robert Rifkin, MD from Rocky Mountain Cancer Center discusses development of a predictive model of multiple myeloma patient outcomes and based on treatment class transitions using patient registry at the 2017 American Society of Hematology.
Development of a Predictive Model of MM Patient Outcomes – Based on Treatment Class Transitions using patient registry
